In this regard, a high IGF-1 gene expression signature mediating cancer proliferation and survival has been assessed in TNBC cells and primary TNBC specimens, hence suggesting a rationale for targeting the IGF-1/IGF-1R system in this highly aggressive breast cancer subtype [17]. The gene discussed is IGF1R; the disease is breast cancer.